Bristol-Myers Squibb
BMY
BMY
1,689 hedge funds and large institutions have $66.2B invested in Bristol-Myers Squibb in 2018 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 578 increasing their positions, 768 reducing their positions, and 134 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 578 | Existing positions reduced: 768
31% less first-time investments, than exits
New positions opened: 93 | Existing positions closed: 134
34% less funds holding in top 10
Funds holding in top 10: 59 → 39 (-20)
Holders
1,689
Holding in Top 10
39
Calls
$1.74B
Puts
$1.49B
Top Buyers
| 1 | +$459M | |
| 2 | +$430M | |
| 3 | +$416M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$407M |
| 5 |
D.E. Shaw & Co
New York
|
+$296M |
Top Sellers
| 1 | -$488M | |
| 2 | -$350M | |
| 3 | -$254M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$221M |
| 5 |
Renaissance Technologies
New York
|
-$220M |